Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to Complex I-related impairment of mitochondrial oxidative phosphorylation
US10307389B2 · kind B2 · utility
2Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 2015 |
| Grant date | Jun 4, 2019 |
| Priority date | — |
| Expiry date | Apr 8, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P39/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a succinate prodrug for use in the treatment or prevention of lactic acidosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.